The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti-inflammatory Biologics Market Research Report 2025
Synopsis
The biologics used in Anti-inflammatory treatment – abatacept (Orencia), adalimumab (Humira), anakinra (Kineret), etanercept (Enbrel), infliximab (Remicade) and rituximab (Rituxan) – block triggers of inflammation. Biologics may be used alone or in combination with a traditional DMARD to treat autoimmune forms of arthritis, such as RA juvenile idiopathic arthritis (JIA), ankylosing spondylitis or psoriasis/psoriatic arthritis. Biologics are given as an injection or infusion, and as such, there is always a risk of an injection site reaction or an infusion reaction.
The global Anti-inflammatory Biologics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Anti-inflammatory Biologics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anti-inflammatory Biologics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Anti-inflammatory Biologics include AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Sun Pharmaceutical Industries Ltd and Sanofi, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Biologics.
Report Scope
The Anti-inflammatory Biologics market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-inflammatory Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-inflammatory Biologics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Sun Pharmaceutical Industries Ltd
Sanofi
GlaxoSmithKline
Segment by Type
Synthetic Type
Biological Type
Segment by Application
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-inflammatory Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-inflammatory Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The biologics used in Anti-inflammatory treatment – abatacept (Orencia), adalimumab (Humira), anakinra (Kineret), etanercept (Enbrel), infliximab (Remicade) and rituximab (Rituxan) – block triggers of inflammation. Biologics may be used alone or in combination with a traditional DMARD to treat autoimmune forms of arthritis, such as RA juvenile idiopathic arthritis (JIA), ankylosing spondylitis or psoriasis/psoriatic arthritis. Biologics are given as an injection or infusion, and as such, there is always a risk of an injection site reaction or an infusion reaction.
The global Anti-inflammatory Biologics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Anti-inflammatory Biologics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anti-inflammatory Biologics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Anti-inflammatory Biologics include AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Sun Pharmaceutical Industries Ltd and Sanofi, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Biologics.
Report Scope
The Anti-inflammatory Biologics market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-inflammatory Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-inflammatory Biologics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Sun Pharmaceutical Industries Ltd
Sanofi
GlaxoSmithKline
Segment by Type
Synthetic Type
Biological Type
Segment by Application
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-inflammatory Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-inflammatory Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Anti-inflammatory Biologics Market Overview
1.1 Product Overview and Scope of Anti-inflammatory Biologics
1.2 Anti-inflammatory Biologics Segment by Type
1.2.1 Global Anti-inflammatory Biologics Market Value Comparison by Type (2024-2030)
1.2.2 Synthetic Type
1.2.3 Biological Type
1.3 Anti-inflammatory Biologics Segment by Application
1.3.1 Global Anti-inflammatory Biologics Market Value by Application: (2024-2030)
1.3.2 Arthritis
1.3.3 Respiratory Diseases
1.3.4 Dermatology
1.3.5 Gastroenterology
1.3.6 Others
1.4 Global Anti-inflammatory Biologics Market Size Estimates and Forecasts
1.4.1 Global Anti-inflammatory Biologics Revenue 2019-2030
1.4.2 Global Anti-inflammatory Biologics Sales 2019-2030
1.4.3 Global Anti-inflammatory Biologics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-inflammatory Biologics Market Competition by Manufacturers
2.1 Global Anti-inflammatory Biologics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-inflammatory Biologics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-inflammatory Biologics Average Price by Manufacturers (2019-2024)
2.4 Global Anti-inflammatory Biologics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-inflammatory Biologics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-inflammatory Biologics, Product Type & Application
2.7 Anti-inflammatory Biologics Market Competitive Situation and Trends
2.7.1 Anti-inflammatory Biologics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-inflammatory Biologics Players Market Share by Revenue
2.7.3 Global Anti-inflammatory Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-inflammatory Biologics Retrospective Market Scenario by Region
3.1 Global Anti-inflammatory Biologics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-inflammatory Biologics Global Anti-inflammatory Biologics Sales by Region: 2019-2030
3.2.1 Global Anti-inflammatory Biologics Sales by Region: 2019-2024
3.2.2 Global Anti-inflammatory Biologics Sales by Region: 2025-2030
3.3 Global Anti-inflammatory Biologics Global Anti-inflammatory Biologics Revenue by Region: 2019-2030
3.3.1 Global Anti-inflammatory Biologics Revenue by Region: 2019-2024
3.3.2 Global Anti-inflammatory Biologics Revenue by Region: 2025-2030
3.4 North America Anti-inflammatory Biologics Market Facts & Figures by Country
3.4.1 North America Anti-inflammatory Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-inflammatory Biologics Sales by Country (2019-2030)
3.4.3 North America Anti-inflammatory Biologics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-inflammatory Biologics Market Facts & Figures by Country
3.5.1 Europe Anti-inflammatory Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-inflammatory Biologics Sales by Country (2019-2030)
3.5.3 Europe Anti-inflammatory Biologics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-inflammatory Biologics Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-inflammatory Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-inflammatory Biologics Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti-inflammatory Biologics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-inflammatory Biologics Market Facts & Figures by Country
3.7.1 Latin America Anti-inflammatory Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-inflammatory Biologics Sales by Country (2019-2030)
3.7.3 Latin America Anti-inflammatory Biologics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-inflammatory Biologics Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-inflammatory Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-inflammatory Biologics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-inflammatory Biologics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anti-inflammatory Biologics Sales by Type (2019-2030)
4.1.1 Global Anti-inflammatory Biologics Sales by Type (2019-2024)
4.1.2 Global Anti-inflammatory Biologics Sales by Type (2025-2030)
4.1.3 Global Anti-inflammatory Biologics Sales Market Share by Type (2019-2030)
4.2 Global Anti-inflammatory Biologics Revenue by Type (2019-2030)
4.2.1 Global Anti-inflammatory Biologics Revenue by Type (2019-2024)
4.2.2 Global Anti-inflammatory Biologics Revenue by Type (2025-2030)
4.2.3 Global Anti-inflammatory Biologics Revenue Market Share by Type (2019-2030)
4.3 Global Anti-inflammatory Biologics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-inflammatory Biologics Sales by Application (2019-2030)
5.1.1 Global Anti-inflammatory Biologics Sales by Application (2019-2024)
5.1.2 Global Anti-inflammatory Biologics Sales by Application (2025-2030)
5.1.3 Global Anti-inflammatory Biologics Sales Market Share by Application (2019-2030)
5.2 Global Anti-inflammatory Biologics Revenue by Application (2019-2030)
5.2.1 Global Anti-inflammatory Biologics Revenue by Application (2019-2024)
5.2.2 Global Anti-inflammatory Biologics Revenue by Application (2025-2030)
5.2.3 Global Anti-inflammatory Biologics Revenue Market Share by Application (2019-2030)
5.3 Global Anti-inflammatory Biologics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AbbVie Anti-inflammatory Biologics Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson Anti-inflammatory Biologics Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Amgen Inc
6.3.1 Amgen Inc Corporation Information
6.3.2 Amgen Inc Description and Business Overview
6.3.3 Amgen Inc Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Amgen Inc Anti-inflammatory Biologics Product Portfolio
6.3.5 Amgen Inc Recent Developments/Updates
6.4 AstraZeneca PLC
6.4.1 AstraZeneca PLC Corporation Information
6.4.2 AstraZeneca PLC Description and Business Overview
6.4.3 AstraZeneca PLC Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AstraZeneca PLC Anti-inflammatory Biologics Product Portfolio
6.4.5 AstraZeneca PLC Recent Developments/Updates
6.5 Pfizer, Inc
6.5.1 Pfizer, Inc Corporation Information
6.5.2 Pfizer, Inc Description and Business Overview
6.5.3 Pfizer, Inc Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer, Inc Anti-inflammatory Biologics Product Portfolio
6.5.5 Pfizer, Inc Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novartis Anti-inflammatory Biologics Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche Anti-inflammatory Biologics Product Portfolio
6.7.5 Roche Recent Developments/Updates
6.8 Sun Pharmaceutical Industries Ltd
6.8.1 Sun Pharmaceutical Industries Ltd Corporation Information
6.8.2 Sun Pharmaceutical Industries Ltd Description and Business Overview
6.8.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Product Portfolio
6.8.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sanofi Anti-inflammatory Biologics Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Corporation Information
6.10.2 GlaxoSmithKline Description and Business Overview
6.10.3 GlaxoSmithKline Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 GlaxoSmithKline Anti-inflammatory Biologics Product Portfolio
6.10.5 GlaxoSmithKline Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-inflammatory Biologics Industry Chain Analysis
7.2 Anti-inflammatory Biologics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-inflammatory Biologics Production Mode & Process
7.4 Anti-inflammatory Biologics Sales and Marketing
7.4.1 Anti-inflammatory Biologics Sales Channels
7.4.2 Anti-inflammatory Biologics Distributors
7.5 Anti-inflammatory Biologics Customers
8 Anti-inflammatory Biologics Market Dynamics
8.1 Anti-inflammatory Biologics Industry Trends
8.2 Anti-inflammatory Biologics Market Drivers
8.3 Anti-inflammatory Biologics Market Challenges
8.4 Anti-inflammatory Biologics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
